eli lilly lawsuit tirzepatide update Zepbound [2026] Novo Nordisk Files Lawsuit Against

Someone looking to lose weight without prescriptions can use methods that support body weight reduction, boost metabolism, and improve digestion

References Clinical Implementation of GLP-1 Receptor Agonists Brown, E., Heerspink, H

Although Hims & Hers relationship with Novo may have ended, the company has an existing partnership 3 with Eli Lilly, in which they are permitted to sell Zepbound, a GLP-1 approved by the FDA for weight loss, and Mounjaro, which is not approved for weight loss but for the treatment of type 2 diabetes

Quick Answer: No clinically relevant interactions are expected between Wegovy (semaglutide) and typical cold remedy ingredients, but individual tolerance may vary due to Wegovy's gastrointestinal effects